Xiaoyang Xu
Molecular Biology · Advanced Drug Delivery Reviews · 2012–2015
A researcher in the Science corpus: 3 papers; trusts 8 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 97 citations into it
- Biomaterials — 79 citations into it
- Biomedical Engineering — 61 citations into it
- Cancer Research — 17 citations into it
Whom Xiaoyang Xu trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Mark E. Davis
- O. Farokhzad
- Mauro Ferrari
- Y. Barenholz
- H. Maeda
- Vladimir Torchilin
- N. Bertrand
- Robert Langer
- George M. Whitesides
- Kathryn A. Whitehead
Papers from Xiaoyang Xu's perspective
Ordered by how strongly the researchers Xiaoyang Xu trusts endorse each paper. Same corpus, a different order for every researcher.
- Nanoparticle therapeutics: an emerging treatment modality for cancer (Nature reviews. Drug discovery)
- Nanoparticle-mediated cellular response is size-dependent. (Nature Nanotechnology)
- Recent advances with liposomes as pharmaceutical carriers (Nature reviews. Drug discovery)
- Effect of pegylation on pharmaceuticals (Nature reviews. Drug discovery)
- Delivering nanomedicine to solid tumors (Nature Reviews Clinical Oncology)
- Understanding biophysicochemical interactions at the nano-bio interface. (Nature Materials)
- Mediating tumor targeting efficiency of nanoparticles through design. (Nano letters (Print))
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles (Nature)
- Role of extracellular matrix assembly in interstitial transport in solid tumors. (Cancer Research)
- Polymer conjugates as anticancer nanomedicines (Nature Reviews. Cancer)
Their papers
- Interactions of nanomaterials and biological systems: implications to personalized nanomedicine (2012) — 406 citations
- Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. (2014) — 2,587 citations
- Cancer Nanomedicine: From Targeted Delivery to Combination Therapy (2015) — 644 citations